173 related articles for article (PubMed ID: 17894944)
1. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
Choi HS; Lee JH; Park JG; Lee YI
Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
6. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
Zhang Y; Dufau ML
J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
[TBL] [Abstract][Full Text] [Related]
7. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
Xiao H; Hasegawa T; Isobe K
J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
[TBL] [Abstract][Full Text] [Related]
8. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
[TBL] [Abstract][Full Text] [Related]
9. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
[TBL] [Abstract][Full Text] [Related]
10. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.
Xiao H; Hasegawa T; Isobe K
J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
12. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
14. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.
Wooten LG; Ogretmen B
J Biol Chem; 2005 Aug; 280(32):28867-76. PubMed ID: 15951564
[TBL] [Abstract][Full Text] [Related]
15. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.
Zhang Y; Liao M; Dufau ML
Mol Cell Biol; 2006 Sep; 26(18):6748-61. PubMed ID: 16943418
[TBL] [Abstract][Full Text] [Related]
17. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
Bu Y; Gelman IH
J Biol Chem; 2007 Sep; 282(37):26725-26739. PubMed ID: 17626016
[TBL] [Abstract][Full Text] [Related]
18. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
19. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
Walker GE; Wilson EM; Powell D; Oh Y
Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
[TBL] [Abstract][Full Text] [Related]
20. GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site.
Dishart D; Schnur N; Klan N; Werz O; Steinhilber D; Samuelsson B; Rådmark O
Biochim Biophys Acta; 2005 Dec; 1738(1-3):37-47. PubMed ID: 16413224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]